David James Lennon, CHIEF EXECUTIVE OFFICER at Whitehawk Therapeutics, Inc. (WHWK), sold 14,500 shares at $3.38 ($49K) on 2026-04-09, disclosed to the SEC on 2026-04-10.
Open-market sale of $49k WHWK by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| WHWK | SELL | 2026-03-10 | $17K | — | Filing → |
| AADI | SELL | 2025-03-03 | $13K | — | Filing → |
| AADI | SELL | 2024-10-03 | $19K | — | Filing → |